Protagenic Therapeutics, Inc.\new Derivative Liability
Protagenic Therapeutics, Inc.\new (PTIX) had Derivative Liability of $544.35 thousand as of 2025-12-31, per its 10-Q filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2026-08-14
- 2025-12-31: Derivative Liability $544.35K.
- 2025-09-30: Derivative Liability $3.66M.
- 2025-06-30: Derivative Liability $3.86M.
- 2025-03-31: Derivative Liability $1.38M.
| Period end | Derivative Liability |
|---|---|
| 2025-12-31 | $544.35K 10-Q · filed 2026-03-09 |
| 2025-09-30 | $3.66M 10-Q · filed 2025-11-26 |
| 2025-06-30 | $3.86M 10-QT · filed 2025-09-10 |
| 2025-03-31 | $1.38M 10-K · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |